不稳定的胸痛. 血小板行为和预后在渐进性心痛和中级冠状动脉综合征
P Grande1, A M Grauholt, J K Madsen
1Medical Department B (Cardiology), Rigshospitalet, University Hospital, Copenhagen, Denmark.
Circulation
|January 1, 1990
概括
患有中级冠状动脉综合征的患者表现出血小板过度聚集和血小板 B2 的升高,表明血小板行为发生了变化. 这与渐进性胸痛患者形成鲜明对比,表明不稳定的胸痛有不同的病理生理机制.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 血栓形成的原因是血栓形成.
背景情况:
- 不稳定的心痛包括中等冠状动脉综合征 (休息疼痛,ST抑郁症) 和渐进性心痛等疾病.
- 血小板激活在急性冠状动脉综合征的病理生理学中起着至关重要的作用.
- 了解不同不稳定性胸痛子组的不同血小板行为对于预后和治疗至关重要.
研究的目的:
- 为了比较中等冠状动脉综合征患者的血小板聚合和激活标志物与渐进性心痛.
- 评估血小板行为与健康对照的关系.
主要方法:
- 活体血小板聚合试验使用阿拉基酸.
- 测量血清血红素B2,血β血红蛋白和血小板因子的测量 4.
- 在13名中期冠状动脉综合征患者,14名慢性心痛患者和20名健康对照患者之间进行了比较.
主要成果:
- 与对照组相比,两个不稳定的心痛组都显示出血小板过度聚集 (p < 0.01).
- 中级冠状动脉综合征患者的血清血红素B2,血β血红球蛋白和血小板因子4显著增加 (p < 0.01).
- 与对照组相比,渐进性胸痛患者的这些标志物水平没有显著不同.
结论:
- 患有中级冠状动脉综合征的患者表现出严重改变的血小板行为,其特征是过度聚合和激活标志物的增加.
- 在中级冠状动脉综合征中,这些血小板变化与在渐进性心痛中观察到的不同.
- 中级冠状动脉综合征中血小板行为的改变可能与冠状动脉血栓的更高频率和更差的预后相关.
相关概念视频
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina I: Introduction
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Angina II: Classification
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina III: Clinical Manifestations and Assessment
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...


